Skip to main content

Transcend Wealth Collective, LLC

SEC CIK
0001776082
Latest filing
Aug 4, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by Transcend Wealth Collective, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
6,659
Value
$1.26M
% of portfolio
0.1%
Quarters held
20
Since Q1 2021
Holdings of AZN by Transcend Wealth Collective, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,659$1.26M0.1%−817−10.9%ReducedHolders
Q1 20267,476$1.47M0.1%−124−1.6%ReducedConverted for a 1-for-2 splitHolders
Q4 202515,199$1.40M0.1%−1,374−8.3%ReducedHolders
Q3 202516,573$1.27M0.1%−1,702−9.3%ReducedHolders
Q2 202518,275$1.28M0.1%−34,616−65.4%ReducedHolders
Q1 202552,891$3.89M0.3%−19,729−27.2%ReducedHolders
Q4 202472,620$4.76M0.3%−5,397−6.9%ReducedHolders
Q3 202478,017$6.08M0.4%+105+0.1%AddedHolders
Q2 202477,912$6.08M0.4%+56,397+262.1%AddedHolders
Q1 202421,515$1.46M0.1%+21,515NewHolders
Q3 20230$00.0%−2,967−100.0%Sold outHolders
Q2 20232,967$212.3K<0.1%−254−7.9%ReducedHolders
Q1 20233,221$223.6K<0.1%−1,224−27.5%ReducedHolders
Q4 20224,445$301.4K<0.1%−416−8.6%ReducedHolders
Q3 20224,861$267.0K<0.1%−787−13.9%ReducedHolders
Q2 20225,648$373.0K<0.1%+203+3.7%AddedHolders
Q1 20225,445$361.0K<0.1%+138+2.6%AddedHolders
Q4 20215,307$309.0K<0.1%+776+17.1%AddedHolders
Q3 20214,531$282.0K<0.1%−6−0.1%ReducedHolders
Q2 20214,537$271.0K<0.1%−2,388−34.5%ReducedHolders
Q1 20216,925$346.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.